Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the in Vivo Efficacy of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex

NCT02212587 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02212587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the in Vivo Efficacy of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex
Lead sponsor
Unity Health Toronto
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2014
Completion date
May 31, 2016
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

burkholderia cepacia infection, cystic fibrosis